RxDoctor Payments Data

Mehmet Aktas, MD

Clinical Cardiac Electrophysiology · Rochester, NYNPI 1689680498

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $6,285 of the $9,437 with a category attached, or 66.6%. 5 manufacturers reported payments, led by Abbott at 56.1% of the total. Reporting peaked in 2022 at $4,349 and has fallen 72.4% since, to $1,201 in 2024. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NY, where the typical reported total is $18,433.

$9,437in general payments, 2019–2025

Across 52 payments — averaging $181.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Boston Scientific$3K
  • Medtronic$430
  • Biosense Webster, Inc.$233
  • Sanofi-aventis U.S. LLC$15
$406,610in research payments, 2019–2025

Across 25 payments — averaging $16,264 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$303K
  • Boston Scientific$56K
  • Biosense Webster, Inc.$31K
  • Medtronic$17K

What the payments were for

  • Consulting fees$7508%
  • Travel & lodging$6,28567%
  • Food & beverage$2,40125%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott28$5,298
Boston Scientific16$3,461
Medtronic(2 entities)5$430
Biosense Webster, Inc.2$233
Sanofi-aventis U.S. LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,437 in reported general payments places this provider in the 30th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$92,801
Medicare patients
348
Services billed
962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$32,573
XareltoRivaroxaban11$8,674
Flecainide Acetate43$1,133
Metoprolol Succinate77$859
Amiodarone Hcl23$848
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$711
Warfarin Sodium12$137
Carvedilol12$126
Metoprolol Tartrate16$102

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →